Skip to content
  • Investors
    • Overview
    • News
    • Events and Presentations
    • Stock Info
    • Financials
    • Governance
    • Resources
  • Join Us
Femasys Logo
  • About Us
    • Overview
    • Leadership
    • Board of Directors
  • Our Focus
  • Our Pipeline
    • Portfolio
    • Clinical Stage
    • Commercial
  • Resources
  • Contact Us
  • About Us
    • Overview
    • Leadership
    • Board of Directors
  • Our Focus
  • Our Pipeline
    • Portfolio
    • Clinical Stage
    • Commercial
  • Resources
  • Contact Us
  • Investors
    • Overview
    • News
    • Events and Presentations
    • Stock Info
    • Financials
    • Governance
    • Resources
  • Join Us
Femasys Logo
  • About Us
    • Overview
    • Leadership
    • Board of Directors
  • Our Focus
  • Our Pipeline
    • Portfolio
    • Clinical Stage
    • Commercial
  • Resources
  • Contact Us
  • Investors
    • Overview
    • News
    • Events and Presentations
    • Stock Info
    • Financials
    • Governance
    • Resources
  • Join Us

Media

CEO & Founder of Femasys, Kathy Lee-Sepsick, on Leading in Women’s Health Tech for 18 Years

Media / By lsc-webmaster

Femasys Inc. Announces the Appointment of Dov Elefant to New Position of Chief Financial Officer

Media / By lsc-webmaster

Femasys Inc. Announces the Appointment of Wendy Perrow, Transformational Biotech Entrepreneur, as New Board Member | BioSpace

Media / By walid

CEO to CEO: Tips for First-time Founders | BioSpace

Media / By walid

Femasys Targets Fertility and Women’s Health – Medical Product Outsourcing (mpo-mag.com)

Media / By walid

Femasys Creates Products and Procedures for the Fallopian Tubes

Media / By lsc-webmaster

Advancements in Technologies Changing Reproductive Healthcare with Kathy Lee-Sepsick

Media / By lsc-webmaster

Femasys: Revolutionizing Female Reproduction (NASDAQ:FEMY)

Media / By lsc-webmaster

Anne Morrissey Joins Femasys as a New Board Member to Help Advance FEMASEED into Clinical Development

Media / By lsc-webmaster

Chardan Acts as Lead Left Bookrunner in Femasys’ $34.45 Million IPO

Media / By lsc-webmaster
Posts navigation
1 2 Next Page →

Recent Posts

  • CEO & Founder of Femasys, Kathy Lee-Sepsick, on Leading in Women’s Health Tech for 18 Years
  • Femasys Inc. Announces the Appointment of Dov Elefant to New Position of Chief Financial Officer
  • Femasys Inc. Announces the Appointment of Wendy Perrow, Transformational Biotech Entrepreneur, as New Board Member | BioSpace
  • CEO to CEO: Tips for First-time Founders | BioSpace
  • Femasys Targets Fertility and Women’s Health – Medical Product Outsourcing (mpo-mag.com)

Recent Comments

No comments to show.

Archives

  • May 2022
  • February 2022
  • January 2022
  • December 2021
  • July 2021
  • June 2021
  • May 2021

Categories

  • Board of Directors
  • Leadership
  • Media

Femasys Color Logo

  • Privacy & Terms
  • Patents
  • Accessibility

Copyright © 2022  Femasys Inc.

FemaSeed, FemBloc, FemCerv, and FemVue are registered trademarks of Femasys Inc. FemCath and FemEMB are trademarks of Femasys Inc.